Our long term goal is to identify regions and specific amino acids within the steroidogenic P450s which play key roles in the unique substrate specificities of their hydroxylation reactions. In the adrenal cortex of most species two mitochondrial P450s (P450scc and P45011Beta) and two microsomal P450s (P45017alpha and P450C21) are involved in the biosynthesis from cholesterol of glucocorticoids (cortisol), mineralocorticoids (aldosterone) and the C19 androgen precursors of the sex hormones. Like most forms of P450 involved in endogenous substrate metabolism, these steroid hydroxylases demonstrate a high degree of substrate specificity both with respect to the steroids which they bind and the stereospecificity of their hydroxylation reactions. We will utilize mutagenesis and expression in bacteria to examine the requirements for both properties of these enzymes. We have developed procedures for relatively high level expression of functional forms of P45017alpha and P450scc in E. coli. Accordingly we propose specific mutagenic experiments to investigate these two steroid hydroxylases in this facile expression system which readily permits not only evaluation of enzymatic properties but also spectral characteristics (substrate-binding and heme-binding) of the mutant enzymes. The ability to easily examine the spectral properties of these enzymes in bacteria provides us the opportunity to estimate the effect of mutagenesis on the structural properties of steroid hydroxylase, as well as on their enzymatic properties. We will also develop E. coli systems expressing P45011beta and P450C21 to be used in similar mutagenesis experiments. In addition we will use the bacterial expression system to evaluate structure/function relationships of mutant forms of human P45017alpha from individuals having 17alpha-hydroxylase deficiency. We will also purify and characterize the cytosolic bacterial reductase which supports P45017alpha activities in intact bacteria. Finally we will develop procedures for purification of P45017alpha and P450scc from bacterial membranes to be used for detailed biophysical studies and crystallization. These studies will provide detailed information on the structure/function relationships of the adrenocortical steroid hydroxylases in particular and P450s in general and surely will broaden our understanding of this superfamily of gene products.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM037942-07
Application #
3293810
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1992-07-18
Project End
1996-03-31
Budget Start
1992-07-18
Budget End
1993-03-31
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Oyama, Tsunehiro; Kagawa, Norio; Sugio, Kenji et al. (2009) Expression of aromatase CYP19 and its relationship with parameters in NSCLC. Front Biosci (Landmark Ed) 14:2285-92
Miller, Todd W; Shin, Incheol; Kagawa, Norio et al. (2008) Aromatase is phosphorylated in situ at serine-118. J Steroid Biochem Mol Biol 112:95-101
Tosha, Takehiko; Kagawa, Norio; Arase, Miharu et al. (2008) Interaction between substrate and oxygen ligand responsible for effective O-O bond cleavage in bovine cytochrome P450 steroid 21-hydroxylase proved by Raman spectroscopy. J Biol Chem 283:3708-17
Zollner, Andy; Kagawa, Norio; Waterman, Michael R et al. (2008) Purification and functional characterization of human 11beta hydroxylase expressed in Escherichia coli. FEBS J 275:799-810
Podust, Larissa M; von Kries, Jens P; Eddine, Ali Nasser et al. (2007) Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography. Antimicrob Agents Chemother 51:3915-23
Lamb, David C; Guengerich, F Peter; Kelly, Steven L et al. (2006) Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery. Expert Opin Drug Metab Toxicol 2:27-40
Lamb, David C; Kim, Youngchang; Yermalitskaya, Liudmila V et al. (2006) A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Structure 14:51-61
Sherman, David H; Li, Shengying; Yermalitskaya, Liudmila V et al. (2006) The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae. J Biol Chem 281:26289-97
Tosha, Takehiko; Kagawa, Norio; Ohta, Takehiro et al. (2006) Raman evidence for specific substrate-induced structural changes in the heme pocket of human cytochrome P450 aromatase during the three consecutive oxygen activation steps. Biochemistry 45:5631-40
Arase, Miharu; Waterman, Michael R; Kagawa, Norio (2006) Purification and characterization of bovine steroid 21-hydroxylase (P450c21) efficiently expressed in Escherichia coli. Biochem Biophys Res Commun 344:400-5

Showing the most recent 10 out of 82 publications